Gossamer Bio, Inc. (GOSS)
0.4224
-0.03
(-6.55%)
USD |
NASDAQ |
Mar 20, 16:00
0.3955
-0.03
(-6.37%)
After-Hours: 06:06
Gossamer Bio EPS Diluted (Quarterly) : -0.2085 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Vanda Pharmaceuticals, Inc. | -2.389 |
| Madrigal Pharmaceuticals, Inc. | -2.566 |
| Kyntra Bio, Inc. | -3.611 |
| Artelo Biosciences, Inc. | -6.191 |
| Axsome Therapeutics, Inc. | -0.5641 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -47.24M |
| Revenue (Quarterly) | 13.80M |
| Total Expenses (Quarterly) | 61.04M |
| Enterprise Value | 163.74M |
| Gross Profit Margin (Quarterly) | 98.36% |
| Profit Margin (Quarterly) | -342.3% |
| Earnings Yield | -177.5% |
| Normalized Earnings Yield | -172.11 |